Evaluation and / or selection methods of inhibitor of odors caused by aldehyde

Abstract

To search a material capable of selectively suppressing odors caused by aldehyde.SOLUTION: Evaluation and / or selection methods of an inhibitor of odors caused by aldehyde include a process of measuring a response of at least one type of olfactory receptor polypeptide selected from a group comprising OR5AR1, OR2AP1, OR5T3, OR6P1, OR51B6, OR10H5, OR2B2, and OR2A1 after addition of a test substance, and polypeptides having the same function as these.SELECTED DRAWING: None

Description

[Technical field]

[0001] The present invention relates to a method for discovering perfume materials that suppress odors caused by aldehydes. [Background technology]

[0002] In our living environment, there are many malodorous molecules with different polarities and molecular weights, and aldehydes are one of them. Aldehydes include compounds known to be the cause of body odor, such as nonenal, octenal, octanal, and isovaleric aldehyde, as well as specific malodorous substances designated under the Offensive Odor Prevention Law (e.g., Patent Documents 1 and 2). Technology that can suppress odors caused by aldehydes will lead to the solution of these malodorous issues.

[0003] As a measure against odors caused by aldehydes, deodorizing technology has been proposed that absorbs and decomposes the odor-causing substances to reduce their amount, but it takes time for the odor substances to be reduced, so it lacks immediate effectiveness. In addition, technology has been proposed that masks the odors using fragrances that have a stronger smell than aldehydes, but this technology does not eliminate the odor caused by aldehydes, and cannot fundamentally eliminate the odor caused by aldehydes. In addition, the odor of the fragrance may cause discomfort.

[0004] In mammals such as humans, odors are recognized when odor molecules bind to olfactory receptors on olfactory nerve cells present in the olfactory epithelium in the upper part of the nasal cavity, and the receptor response to this is transmitted to the central nervous system. In humans, it has been reported that there are about 400 types of olfactory receptors, and the genes that code for these account for about 2% of all human genes. In general, olfactory receptors and odor molecules correspond in a multiple-to-multiple combination. That is, each olfactory receptor receives multiple odor molecules with similar structures with different affinities, while each odor molecule is received by multiple types of olfactory receptors. In addition, it has been reported that an odor molecule that activates a certain olfactory receptor acts as an antagonist that inhibits the activation of another olfactory receptor. The combination of responses of these multiple types of olfactory receptors results in the recognition of each odor.

[0005] In the past, in the development of fragrance substances, the odor of candidate substances was evaluated by sensory testing by experts. However, sensory testing has problems such as the need to train experts who can evaluate odors and low throughput. In recent years, a method for searching for fragrance substances using the response of olfactory receptors to candidate substances as an index has been developed (Patent Document 3). Since the response of olfactory receptors is selective to odor substances, it is essential to first find an olfactory receptor that has selectivity for the target odor. If such an olfactory receptor is identified, for example, when the purpose is to eliminate a bad odor, an approach based on olfactory receptor suppression by an antagonist or cross-adaptation by an agonist becomes possible. In other words, it becomes possible to more effectively suppress odors caused by aldehydes, which are bad odors. In fact, several olfactory receptors that respond to aldehydes have been identified so far. For example, OR1D2, OR2C1, OR2J2, OR4E2, OR5P3, and OR52N2 have been identified as olfactory receptors that respond to trans-2-nonenal, and OR2C1, OR2J2, OR4E2, OR5P3, OR7G1, OR9I1, and OR51A7 have been identified as olfactory receptors that respond to trans-2-octenal (Patent Document 1). However, existing receptor analysis methods have only succeeded in functional analysis of about 12% of all human receptors (Non-Patent Document 1). Thus, the olfactory system has not yet been elucidated, and therefore, there has been a problem in that it is not easy to find all olfactory receptors that are sensitive to a specific odor by a molecular biological approach.

[0006] The reason why most olfactory receptors have not been successfully analyzed is that even if the olfactory receptor polypeptide of interest is produced in cultured cells, it does not migrate to the surface of the cell (membrane expression) but remains in the endoplasmic reticulum. Therefore, it is not possible to evaluate the binding to odorants administered from outside the cell. The reason why olfactory receptors are not expressed on the membrane has long been unknown, but in recent years, mouse olfactory receptors that are expressed on the membrane in cultured cells and mouse olfactory receptors that are not expressed on the membrane have been comparatively analyzed (Non-Patent Document 2). As a result, it was found that olfactory receptors that are not expressed on the membrane may have low stability of their three-dimensional structure. And, importantly, it was shown that there are amino acid positions in the primary amino acid sequence of the protein that are statistically significantly different in Grantham distance between olfactory receptors that can be expressed on the membrane and those that cannot, and that these amino acid positions are amino acids that are highly common in all approximately 1,000 types of mouse olfactory receptors. In other words, it was suggested that olfactory receptors that are not expressed on the membrane lack stability of their three-dimensional structure due to a mutation to a different amino acid at a position in the polypeptide where a common amino acid should be used, and that a decision was made not to migrate to the cell membrane in cultured cells. Taking this into consideration, it is believed that by using the "consensus method," which introduces amino acids that are highly common between olfactory receptors, it will be possible to obtain the desired olfactory receptor as a stable protein and efficiently express it on the cell membrane.

[0007] Based on this idea, in Non-Patent Document 1, a consensus method was used to enable analysis of specific olfactory receptors. Specifically, for the three types of human olfactory receptors OR6Y1, OR6B2, and OR56A4, consensus olfactory receptors OR6Y1, OR6B2, and OR56A4 were produced by introducing amino acids with high commonality between the homologous genes of 10 types of mammals (gorilla, bonobo, chimpanzee, Sumatran orangutan, rhesus monkey, drill, common marmoset, gray mouse lemur, rat, and mouse) into each human olfactory receptor. As a result, it has been disclosed that, of the three types of olfactory receptors, OR6Y1 has become possible to measure the response to odorants using cultured cells. Therefore, it is suggested that although there are receptors for which consensus analysis is possible, the proportion is about 1 / 3.

[0008] The consensus method has been used for a long time to design industrially useful enzymes to be stable. However, according to Non-Patent Document 3, a review of this method, the probability of introducing consensus into a certain amino acid sequence to obtain an improvement effect is about 50%, and the remaining 40% has the risk of worsening the protein, which makes it difficult to use the consensus method. In addition, there is a view that the application of the consensus method is not appropriate in research aimed at estimating the original function of olfactory receptors. In other words, there is a concern that the approach of introducing amino acid substitutions will change the ligand binding site of the original olfactory receptor, and as a result, the original odor responsiveness will not be observed. From the above, consensus is predicted to have two problems: a low success rate and a risk of changing the original function of the target olfactory receptor, so there have been no examples of its effectiveness against a wide range of olfactory receptors.

[0009] Under these circumstances, the present inventors have conducted extensive research into methods for expressing and functioning olfactory receptors on the membrane of cultured cells, and have found that by modifying the amino acid sequence of a target olfactory receptor based on a consensus amino acid sequence derived from an alignment of the amino acid sequence of the target olfactory receptor with the amino acid sequence of an olfactory receptor encoded by a specific ortholog or specific orthologs and paralogs of the target olfactory receptor, according to criteria other than those of the conventional methods, it is possible to improve membrane expression of the modified olfactory receptor in cultured cells compared to the original olfactory receptor, improve the odor responsiveness of the modified olfactory receptor compared to the original olfactory receptor, and even if the membrane expression of the modified olfactory receptor in cultured cells is not improved compared to the original olfactory receptor, the odor responsiveness of the modified olfactory receptor can be improved, and further, the modified olfactory receptor can well maintain the ligand selectivity of the original olfactory receptor before modification, and the analytical results obtained using the modified olfactory receptor well reflect human olfaction (Patent Document 4). [Prior art documents] [Patent documents]

[0010] [Patent Document 1] International Publication No. 2019 / 131789 [Patent Document 2] JP 2017-43567 A [Patent Document 3] JP 2018-74944 A [Patent Document 4] JP 2023-2484 A [Non-patent literature]

[0011] [Non-Patent Document 1] Trimmer C et al. PNAS 116:9475-9480 (2019) [Non-Patent Document 2] Ikegami K et al. PNAS 117:2957-2967 (2020) [Non-Patent Document 3] Porebski TB et al. Protein Engineering, Design & Selection 29:245-251 (2016) Summary of the Invention [Problem to be solved by the invention]

[0012] The present invention provides a method for efficiently evaluating and / or selecting an agent for suppressing odor caused by aldehydes by using the response of olfactory receptors as an indicator. [Means for solving the problem]

[0013] The present inventors have succeeded in identifying a new olfactory receptor that selectively responds to aldehydes by using the consensus method of Patent Document 4. Furthermore, the present inventors have found that by using the response of the olfactory receptor or a polypeptide having a similar function as an indicator, it is possible to efficiently search for a substance that suppresses odors caused by aldehydes and to detect odors caused by aldehydes in a sample.

[0014] Therefore, the present invention provides the following 1) to 4). 1) A method for evaluating and / or selecting an inhibitor of odor caused by aldehydes, comprising measuring the response of at least one olfactory receptor polypeptide selected from the group consisting of OR5AR1, OR2AP1, OR5T3, OR6P1, OR51B6, OR10H5, OR2B2, OR2A1 and polypeptides having equivalent functions thereto after addition of a test substance. 2) A method for evaluating and / or selecting an octanal odor suppressant, comprising measuring the response of at least one olfactory receptor polypeptide selected from the group consisting of OR2C1 and polypeptides having equivalent functions thereto after addition of a test substance. 3) A method for detecting an odor caused by an aldehyde, comprising contacting a sample with at least one olfactory receptor polypeptide selected from the group consisting of OR5AR1, OR2AP1, OR5T3, OR6P1, OR51B6, OR10H5, OR2B2, OR2A1 and polypeptides having equivalent functions thereto, and measuring the response of the olfactory receptor polypeptide to the sample. 4) A method for detecting octanal odor, comprising contacting a sample with at least one olfactory receptor polypeptide selected from the group consisting of OR2C1 and polypeptides having equivalent functions thereto, and measuring the response of the olfactory receptor polypeptide to the sample. Effect of the Invention

[0015] According to the present invention, it is possible to efficiently evaluate or select a substance capable of selectively suppressing an odor caused by aldehyde, and also to detect an odor caused by aldehyde in a sample. DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS

[0016] All patents, non-patent publications, and other publications cited herein are hereby incorporated by reference in their entirety.

[0017] As used herein, the term "agonist" refers to a substance that binds to and activates a receptor, whereas the term "antagonist" refers to a substance that binds to a receptor but does not activate the receptor or suppresses the response of the receptor to an agonist.

[0018] As used herein, "olfactory receptor agonism" refers to binding to a receptor and activating the receptor.

[0019] In this specification, "odor cross-adaptation (or olfactory cross-adaptation)" with respect to a target odor refers to a phenomenon in which olfactory sensitivity to a target odor causative substance is reduced or changed by receiving the odor of a substance other than the target odor causative substance in advance and becoming accustomed to the odor. The present inventors have previously revealed that "odor cross-adaptation" is a phenomenon based on olfactory receptor agonism (International Publication No. 2016 / 194788). That is, in "odor cross-adaptation", the olfactory receptor for the target odor causative substance responds to a different odor causative substance prior to responding to the target odor causative substance, and then desensitizes, so that even if it is later exposed to the target odor causative substance, it can only respond poorly, resulting in a reduction or alteration of the intensity of the target odor recognized by the individual. The mechanism of odor cross-adaptation caused by such behavior of olfactory receptors is also referred to as "odor cross-adaptation due to olfactory receptor agonism" in this specification.

[0020] As used herein, "suppression of a target odor by olfactory receptor antagonism" refers to suppressing the response of an olfactory receptor to a substance having a target odor by an antagonist, thereby suppressing the target odor recognized by an individual.

[0021] As used herein, the term "olfactory receptor polypeptide" refers to an olfactory receptor or a polypeptide having a function equivalent thereto, and the term "polypeptide having a function equivalent to that of an olfactory receptor" refers to a polypeptide that can be expressed on the cell membrane, like an olfactory receptor, is activated by the binding of odor molecules, and, upon activation, has the function of increasing the amount of intracellular cAMP by coupling with intracellular Gαs to activate adenylate cyclase (Nat. Neurosci., 2004, 5:263-278).

[0022] In the present specification, the identity of nucleotide sequences and amino acid sequences is calculated by the Lipman-Pearson method (Science, 1985, 227:1435-41). Specifically, the identity is calculated by performing analysis with a unit size to compare (ktup) of 2 using the search homology program of the genetic information processing software Genetyx-Win (Ver. 5.1.1; software development).

[0023] As used herein, "at least 80% identity" with respect to a nucleotide sequence and an amino acid sequence means 80% or more, preferably 85% or more, more preferably 90% or more, even more preferably 95% or more, even more preferably 98% or more, and even more preferably 99% or more identity. Also, "at least 90% identity" with respect to a nucleotide sequence and an amino acid sequence means 90% or more, preferably 95% or more, more preferably 98% or more, and even more preferably 99% or more identity.

[0024] As used herein, the term "amino acid residue" refers to the 20 types of amino acid residues constituting proteins: alanine (Ala or A), arginine (Arg or R), asparagine (Asn or N), aspartic acid (Asp or D), cysteine ​​(Cys or C), glutamine (Gln or Q), glutamic acid (Glu or E), glycine (Gly or G), histidine (His or H), isoleucine (Ile or I), leucine (Leu or L), lysine (Lys or K), methionine (Met or M), phenylalanine (Phe or F), proline (Pro or P), serine (Ser or S), threonine (Thr or T), tryptophan (Trp or W), tyrosine (Tyr or Y), and valine (Val or V).

[0025] As used herein, amino acid modifications may be designated by the accepted IUPAC one-letter amino acid abbreviations: [original amino acid, position, modified amino acid].

[0026] In the present specification, the "corresponding position" on the amino acid sequence can be determined by aligning the target sequence with the reference sequence (the amino acid sequence shown in SEQ ID NO: 1, 4, 7, 10, 13, 16, 19, 22, or 25 in the present invention) so as to give the maximum homology. Alignment of amino acid sequences can be performed using a known algorithm, and the procedure is known to those skilled in the art. For example, alignment can be performed using the Clustal W multiple alignment program (Thompson, J. D. et al., 1994, Nucleic Acids Res. 22: 4673-4680) with default settings. Alternatively, Clustal W2 or Clustal omega, which are revised versions of Clustal W, can be used. Clustal W, Clustal W2 and Clustal omega are available, for example, on the Clustal website operated by University College Dublin ([www.clustal.org]), the European Bioinformatics Institute (EBI [www.ebi.ac.uk / index.html]), and the website of the DNA Data Bank of Japan operated by the National Institute of Genetics (DDBJ [www.ddbj.nig.ac.jp / searches-j.html]). The position of the target sequence aligned to any position of the reference sequence by the above-mentioned alignment is considered to be a "position corresponding to" the any position.

[0027] In the present specification, the "aldehyde" is not particularly limited, but preferred examples of the aldehyde include trans-2-nonenal and octanal.

[0028] The "odor caused by aldehyde" suppressed by the present invention is an odor caused by the above-mentioned aldehyde, and is preferably an odor caused by at least one selected from the group consisting of trans-2-nonenal and octanal. Trans-2-nonenal and octanal are known as substances causing body odor, and trans-2-nonenal in particular is also known as a substance causing elderly odor. Therefore, typically, the "odor caused by aldehyde" suppressed by the present invention may be body odor or elderly odor.

[0029] The present inventors have previously discovered that by modifying the amino acid sequence of a target olfactory receptor based on a consensus amino acid sequence derived from an alignment of the amino acid sequence of the target olfactory receptor with the amino acid sequence of an olfactory receptor encoded by a specific ortholog or a specific ortholog and paralog of the target olfactory receptor according to unconventional criteria, it is possible to improve the membrane expression of the modified olfactory receptor in cultured cells compared to the original olfactory receptor, improve the odor responsiveness of the modified olfactory receptor compared to the original olfactory receptor, and even if the membrane expression of the modified olfactory receptor in cultured cells is not improved compared to the original olfactory receptor, the odor responsiveness of the modified olfactory receptor can be improved, the modified olfactory receptor can maintain the ligand selectivity of the original olfactory receptor before modification, and the analytical results obtained using the modified olfactory receptor closely reflect the human sense of smell (Patent Document 4). In this specification, the olfactory receptor before modification is referred to as the "original olfactory receptor," modifying the amino acid sequence of an olfactory receptor based on a consensus amino acid sequence is referred to as "consensusization," and the consensus-based olfactory receptor is sometimes referred to as the "consensus olfactory receptor."

[0030] Here, the "consensus amino acid sequence" refers to an amino acid sequence consisting of consensus residues identified from an alignment of the amino acid sequence of a target olfactory receptor and an olfactory receptor encoded by a specific ortholog or a specific ortholog and paralog of the target olfactory receptor (e.g., at least 11 types of olfactory receptors selected from the group consisting of olfactory receptors encoded by orthologs of the target olfactory receptor in mammals) according to the following criteria (i) to (iii). (i) at each amino acid position of the alignment, (ii) if there is one amino acid residue that is different from the amino acid residue of the target olfactory receptor and occurs at a frequency of 50% or more, the amino acid residue is identified as a consensus residue; (i-ii) when there are two amino acid residues with an occurrence frequency of 50%, the amino acid residue of the target olfactory receptor is identified as a consensus residue; (i-iii) if an amino acid residue is present in the olfactory receptor of interest and no amino acid residue is present with an occurrence frequency of 40% or more, it is identified as having no consensus residue; (i-iv) if no amino acid residue is present in the target olfactory receptor and an amino acid residue is present with an occurrence frequency of 60% or more, the most frequently occurring amino acid residue is identified as the consensus residue, and if two or more types of the most frequently occurring amino acid residues are present, the amino acid residue with the smallest molecular weight among the amino acid residues is identified as the consensus residue; (iv) if none of the above (ii) to (i-iv) apply, identifying the amino acid residue of the target olfactory receptor as a consensus residue; (ii) when the consensus residue is identified according to the above criterion (i), if the most N-terminal consensus residue is a consensus residue at a position corresponding to the N-terminus or the C-terminus of the olfactory receptor of interest and is not a methionine residue, the consensus residue N-terminal to the consensus residue consisting of the methionine residue at the position closest to the N-terminus is changed to no consensus residue; (iii) When a consensus residue is identified according to the above criterion (i), if the most N-terminal consensus residue is a consensus residue at a position corresponding to the N-terminal side of the N-terminus of the olfactory receptor of interest and is not a methionine residue, the alignment is traced back one amino acid position at a time toward the N-terminus from the position of the consensus residue until a methionine residue appears, and the most frequently occurring amino acid residue is identified as the consensus residue. If there are two or more types of most frequently occurring amino acid residues, the amino acid residue with the smallest molecular weight among those amino acid residues is identified as the consensus residue. Additionally, herein, "modifying the amino acid sequence of an olfactory receptor based on a consensus amino acid sequence," i.e., "creating a consensus," refers to modifying at least one amino acid residue in the amino acid sequence of the olfactory receptor of interest that differs from the consensus amino acid sequence to an amino acid residue of the consensus amino acid sequence at the corresponding position.

[0031] The above-mentioned consensus olfactory receptor involves the introduction of amino acid mutations into the olfactory receptor, which may at first glance raise concerns that it may provide measurement results that do not accurately reflect the original functions of the original olfactory receptor and human olfactory sensation. However, as shown in Patent Document 4, the consensus olfactory receptor maintains a high degree of ligand response selectivity of the original olfactory receptor and provides measurement results that best explain human olfactory sensation.

[0032] Therefore, although the amino acid sequence of the consensus olfactory receptor has been modified, its responsiveness reflects the responsiveness of the original olfactory receptor in olfactory cells, and its function as an olfactory receptor is equivalent to that of the original olfactory receptor.

[0033] The present inventor found that consensus OR5AR1, consensus OR2AP1, consensus OR5T3, consensus OR6P1, consensus OR51B6, consensus OR10H5, consensus OR2B2, consensus OR2A1 and consensus OR2C1 respond to aldehydes among the olfactory receptors that were subjected to the above-mentioned consensus. As described above, the consensus olfactory receptor maintains the ligand selectivity of the original olfactory receptor to a high degree. That is, the response of the consensus olfactory receptor to a certain odorant reflects the response of the original olfactory receptor to the odorant in the olfactory cell. Therefore, OR5AR1, OR2AP1, OR5T3, OR6P1, OR51B6, OR10H5, OR2B2, OR2A1 and OR2C1 can be identified as olfactory receptors that respond to aldehydes. In particular, OR5AR1 is an olfactory receptor that responds to trans-2-nonenal, and OR2AP1, OR5T3, OR6P1, OR51B6, OR10H5, OR2B2, OR2A1, and OR2C1 are olfactory receptors that respond to octanal.

[0034] It has not been previously recognized that OR5AR1, OR2AP1, OR5T3, OR6P1, OR51B6, OR10H5, OR2B2, and OR2A1 respond or may respond to aldehydes. On the other hand, OR2C1 was known to respond to trans-2-nonenal and trans-2-octenal, but was not previously known to respond to other aldehydes.

[0035] Thus, OR5AR1, OR2AP1, OR5T3, OR6P1, OR51B6, OR10H5, OR2B2, and OR2A1 are newly discovered aldehyde receptors, and OR2C1 is an aldehyde receptor. Substances that suppress the response of OR5AR1, OR2AP1, OR5T3, OR6P1, OR51B6, OR10H5, OR2B2, OR2A1, OR2C1, or polypeptides having equivalent functions thereto, can cause changes in the recognition of odors caused by aldehydes in the central nervous system based on odor suppression by olfactory receptor antagonism, and as a result, can selectively suppress odors caused by aldehydes. On the other hand, substances that enhance the response of OR5AR1, OR2AP1, OR5T3, OR6P1, OR51B6, OR10H5, OR2B2, OR2A1, OR2C1, or polypeptides having similar functions to these, can change the perception of odors caused by aldehydes in the central nervous system based on odor cross-adaptation due to olfactory receptor agonism, and as a result, can selectively suppress odors caused by aldehydes. Therefore, substances that suppress or enhance the response of these polypeptides can deodorize odors caused by aldehydes without causing discomfort due to the strong odor of the fragrance, which occurred in conventional deodorizing methods using deodorants or fragrances, or problems such as suppressing other odors.

[0036] In addition, OR2C1 is a newly discovered octanal receptor. Substances that suppress the response of OR2C1 or polypeptides having a function equivalent thereto cause changes in the recognition of octanal odor in the central nervous system based on odor suppression by olfactory receptor antagonism, and as a result, octanal odor can be selectively suppressed. On the other hand, substances that enhance the response of OR2C1 or polypeptides having a function similar thereto cause changes in the recognition of octanal odor in the central nervous system based on odor cross-adaptation by olfactory receptor agonism, and as a result, octanal odor can be selectively suppressed. Therefore, according to substances that suppress or enhance the response of these polypeptides, it is possible to deodorize octanal odor without causing discomfort due to the strong odor of the fragrance, which occurred in conventional deodorants or deodorizing methods using fragrances, or problems such as suppressing other odors.

[0037] Therefore, the present invention provides a method for evaluating and / or selecting an inhibitor of odor caused by aldehydes. The method includes measuring the response of at least one olfactory receptor polypeptide selected from the group consisting of OR5AR1, OR2AP1, OR5T3, OR6P1, OR51B6, OR10H5, OR2B2, OR2A1, and polypeptides having equivalent functions thereto, after addition of a test substance. The method may further include measuring the response of at least one olfactory receptor polypeptide selected from the group consisting of OR2C1 and polypeptides having equivalent functions thereto, after addition of a test substance. A test substance that enhances or inhibits the response of the olfactory receptor polypeptide is detected based on the measured response. The detected test substance is selected as an inhibitor of odor caused by aldehydes. That is, a test substance that enhances the response of the olfactory receptor polypeptide is selected as an inhibitor of aldehyde-induced odor based on odor cross-adaptation through olfactory receptor agonism, and a test substance that inhibits the response of the olfactory receptor polypeptide is selected as an inhibitor of aldehyde-induced odor based on olfactory receptor antagonism.

[0038] The present invention also provides a method for evaluating and / or selecting an octanal odor suppressant. The method includes measuring the response of at least one olfactory receptor polypeptide selected from the group consisting of OR2C1 and polypeptides having equivalent functions thereto after addition of a test substance. Based on the measured response, a test substance that enhances or suppresses the response of the olfactory receptor polypeptide is detected. The detected test substance is selected as an octanal odor suppressant. That is, a test substance that enhances the response of the olfactory receptor polypeptide is selected as an octanal odor suppressant based on odor cross-adaptation due to olfactory receptor agonism, and a test substance that suppresses the response of the olfactory receptor polypeptide is selected as an octanal odor suppressant based on olfactory receptor antagonism.

[0039] The above-mentioned method of the present invention for evaluating and / or selecting an agent for suppressing odor caused by aldehydes can be carried out in vitro or ex vivo.

[0040] The test substance used in the method for evaluating and / or selecting an agent for suppressing an odor caused by aldehyde of the present invention is not particularly limited as long as it is a substance desired to be used as an agent for suppressing an odor caused by aldehyde. The test substance may be a naturally occurring substance, or a substance artificially synthesized by a chemical or biological method, or may be a compound, composition, or mixture.

[0041] OR5AR1, OR2AP1, OR5T3, OR6P1, OR51B6, OR10H5, OR2B2, OR2A1, and OR2C1 are olfactory receptors expressed in human olfactory cells. The accession numbers and amino acid sequences of each olfactory receptor in the NCBI database are shown in Table 1.

[0042] [Table 1]

[0043] Examples of polypeptides having functions equivalent to OR5AR1 include polypeptides having an amino acid sequence that is at least 80% identical to the amino acid sequence shown in SEQ ID NO:1 and that are responsive to trans-2-nonenal. Another example of a polypeptide having a function equivalent to OR5AR1 is a polypeptide having an amino acid sequence having at least 80% identity with the amino acid sequence shown in SEQ ID NO: 1, having an amino acid residue of (2) at at least one position, preferably at least three positions, more preferably at least five positions, even more preferably at least 10 positions, and even more preferably at all positions corresponding to each amino acid position of (1) in the amino acid sequence shown in SEQ ID NO: 1 in Table 2 below, and having responsiveness to trans-2-nonenal. Yet another example of a polypeptide having a function equivalent to OR5AR1 is a polypeptide having an amino acid sequence having at least 80% identity with the amino acid sequence shown in SEQ ID NO: 1, having an amino acid residue of (2) at preferably at least 10%, more preferably at least 30%, even more preferably at least 50%, even more preferably at least 70%, even more preferably at least 90%, and even more preferably at all positions corresponding to each amino acid position of (1) in the amino acid sequence shown in SEQ ID NO: 1 in Table 2 below, and having responsiveness to trans-2-nonenal. Here, having SVL (10) at the amino acid position corresponding to the C-terminus of (1) in Table 2 below means that in a certain amino acid sequence, SVL is added to the C-terminus side of the position corresponding to the last amino acid position of the amino acid sequence shown in SEQ ID NO: 1. Note that in the amino acid sequence shown in SEQ ID NO: 1, a polypeptide having amino acid residues (2) at all of the amino acid positions of (1) in Table 2 below is consensus OR5AR1 consisting of the amino acid sequence shown in SEQ ID NO: 3. In other words, Table 2 below shows the amino acid residues that differ between OR5AR1 and consensus OR5AR1.

[0044] Another example of a polypeptide having a function equivalent to OR5AR1 includes a consensus OR5AR1 consisting of the amino acid sequence shown in SEQ ID NO: 3 or an amino acid sequence having at least 90% identity thereto, and having responsiveness to trans-2-nonenal. The consensus OR5AR1 is composed of the consensus amino acid sequence shown in SEQ ID NO: 3, which is derived by the above-mentioned method from the alignment of the amino acid sequence of OR5AR1 shown in SEQ ID NO: 1 and the amino acid sequences of 27 olfactory receptors encoded by orthologues of OR5AR1 in mammals, and has responsiveness to trans-2-nonenal. The orthologue is a gene that is highly homologous to OR5AR1 among olfactory receptor genes possessed by organisms belonging to mammals, and is a gene that includes the same name as OR5AR1. The amino acid sequence identity between the consensus OR5AR1 and OR5AR1 is 77%.

[0045] An example of a polypeptide having a function equivalent to OR2AP1 includes a polypeptide having an amino acid sequence having at least 80% identity with the amino acid sequence shown in SEQ ID NO: 4 and having responsiveness to octanal. Another example of a polypeptide having a function equivalent to OR2AP1 is a polypeptide having an amino acid sequence having at least 80% identity with the amino acid sequence shown in SEQ ID NO: 4, at least one, preferably at least three, more preferably at least five, even more preferably at least 10, and even more preferably all of the positions corresponding to the amino acid positions in Table 2 (3) of the amino acid sequence shown in SEQ ID NO: 4, and having an amino acid residue of (4) at each position, and having responsiveness to octanal. Yet another example of a polypeptide having a function equivalent to OR2AP1 is a polypeptide having an amino acid sequence having at least 80% identity with the amino acid sequence shown in SEQ ID NO: 4, at least 10%, more preferably at least 30%, even more preferably at least 50%, even more preferably at least 70%, even more preferably at least 90%, and even more preferably at all of the positions corresponding to the amino acid positions in Table 2 (3) of the amino acid sequence shown in SEQ ID NO: 4, and having an amino acid residue of (4) at each position, and having responsiveness to octanal. In addition, a polypeptide having the amino acid residues (4) at all of the amino acid positions (3) in the amino acid sequence of SEQ ID NO: 4 in Table 2 below is consensus OR2AP1 consisting of the amino acid sequence of SEQ ID NO: 6. In other words, Table 2 below shows the amino acid residues that differ between OR2AP1 and consensus OR2AP1.

[0046] Another example of a polypeptide having a function equivalent to OR2AP1 includes a consensus OR2AP1 consisting of the amino acid sequence shown in SEQ ID NO:6 or an amino acid sequence having at least 90% identity thereto, and having responsiveness to octanal. The consensus OR2AP1 is composed of the consensus amino acid sequence shown in SEQ ID NO: 6, which is derived by the above-mentioned method from the alignment of the amino acid sequence of OR2AP1 shown in SEQ ID NO: 4 and the amino acid sequences of 101 olfactory receptors encoded by orthologues of OR2AP1 in mammals, and is responsive to octanal. The orthologue is a gene that is highly homologous to OR2AP1 among olfactory receptor genes possessed by organisms belonging to mammals, and is a gene that includes the same name as OR2AP1. The amino acid sequence identity between the consensus OR2AP1 and OR2AP1 is 95%.

[0047] An example of a polypeptide having a function equivalent to OR5T3 includes a polypeptide consisting of an amino acid sequence having at least 80% identity with the amino acid sequence shown in SEQ ID NO: 7 and having responsiveness to octanal. Another example of a polypeptide having a function equivalent to OR5T3 is a polypeptide having an amino acid sequence having at least 80% identity with the amino acid sequence shown in SEQ ID NO: 7, at least one position, preferably at least three positions, more preferably at least five positions, even more preferably at least 10 positions, and even more preferably at all positions corresponding to each amino acid position of (5) in Table 2 below of the amino acid sequence shown in SEQ ID NO: 7, and having an amino acid residue of (6) at each position, and having responsiveness to octanal. Yet another example of a polypeptide having a function equivalent to OR5T3 is a polypeptide having an amino acid sequence having at least 80% identity with the amino acid sequence shown in SEQ ID NO: 7, at least 10%, more preferably at least 30%, even more preferably at least 50%, even more preferably at least 70%, even more preferably at least 90%, and even more preferably at all positions corresponding to each amino acid position of (5) in Table 2 below of the amino acid sequence shown in SEQ ID NO: 7, and having an amino acid residue of (6) at each position, and having responsiveness to octanal. In addition, in the amino acid sequence shown in SEQ ID NO: 7, a polypeptide having amino acid residues (6) at all of the amino acid positions (5) in Table 2 below is consensus OR5T3 consisting of the amino acid sequence shown in SEQ ID NO: 9. In other words, Table 2 below shows the amino acid residues that differ between OR5T3 and consensus OR5T3.

[0048] Another example of a polypeptide having a function equivalent to OR5T3 includes a consensus OR5T3 consisting of the amino acid sequence shown in SEQ ID NO: 9 or an amino acid sequence having at least 90% identity thereto, and having responsiveness to octanal. Consensus OR5T3 consists of the consensus amino acid sequence shown in SEQ ID NO: 9, which is derived by the above-mentioned method from the alignment of the amino acid sequence of OR5T3 shown in SEQ ID NO: 7 and the amino acid sequences of 48 olfactory receptors encoded by orthologues of OR5T3 in mammals, and has responsiveness to octanal. The orthologue is a gene that is highly homologous to OR5T3 among olfactory receptor genes possessed by organisms belonging to mammals, and is a gene that includes the same name as OR5T3. The amino acid sequence identity between consensus OR5T3 and OR5T3 is 94%.

[0049] An example of a polypeptide having a function equivalent to OR6P1 includes a polypeptide having an amino acid sequence that is at least 80% identical to the amino acid sequence shown in SEQ ID NO: 10 and that is responsive to octanal. Another example of a polypeptide having a function equivalent to OR6P1 is a polypeptide having an amino acid sequence having at least 80% identity with the amino acid sequence shown in SEQ ID NO: 10, at least one position, preferably at least three positions, more preferably at least five positions, even more preferably at least 10 positions, and even more preferably all positions corresponding to each amino acid position (7) in the amino acid sequence shown in SEQ ID NO: 10 in Table 2 below, and having an amino acid residue (8) at each position, and having responsiveness to octanal. Yet another example of a polypeptide having a function equivalent to OR6P1 is a polypeptide having an amino acid sequence having at least 80% identity with the amino acid sequence shown in SEQ ID NO: 10, at least 10%, more preferably at least 30%, even more preferably at least 50%, even more preferably at least 70%, even more preferably at least 90%, and even more preferably at all positions corresponding to each amino acid position (7) in the amino acid sequence shown in SEQ ID NO: 10 in Table 2 below, and having an amino acid residue (8) at each position, and having responsiveness to octanal. In addition, in the amino acid sequence shown in SEQ ID NO: 10, a polypeptide having amino acid residues (8) at all of the amino acid positions (7) in Table 2 below is consensus OR6P1 consisting of the amino acid sequence shown in SEQ ID NO: 12. In other words, Table 2 below shows the amino acid residues that differ between OR6P1 and consensus OR6P1.

[0050] Another example of a polypeptide having a function equivalent to OR6P1 includes a polypeptide consisting of consensus OR6P1 consisting of the amino acid sequence shown in SEQ ID NO: 12 or an amino acid sequence having at least 90% identity thereto, and having responsiveness to octanal. Consensus OR6P1 consists of the consensus amino acid sequence shown in SEQ ID NO: 12, which is derived by the above-mentioned method from the alignment of the amino acid sequence of OR6P1 shown in SEQ ID NO: 10 and the amino acid sequences of 136 olfactory receptors encoded by orthologues of OR6P1 in mammals, and has responsiveness to octanal. The orthologue is a gene that is highly homologous to OR6P1 among olfactory receptor genes possessed by organisms belonging to mammals, and is a gene that includes the same name as OR6P1. The amino acid sequence identity between consensus OR6P1 and OR6P1 is 94%.

[0051] An example of a polypeptide having a function equivalent to OR51B6 includes a polypeptide consisting of an amino acid sequence having at least 80% identity with the amino acid sequence shown in SEQ ID NO: 13 and having responsiveness to octanal. Another example of a polypeptide having a function equivalent to OR51B6 is a polypeptide having an amino acid sequence having at least 80% identity with the amino acid sequence shown in SEQ ID NO: 13, at least one position, preferably at least three positions, more preferably at least five positions, even more preferably at least 10 positions, and even more preferably at all positions corresponding to each amino acid position of (1) in the amino acid sequence shown in SEQ ID NO: 13 in Table 3 below, and having an amino acid residue of (2) at each position, and having responsiveness to octanal. Yet another example of a polypeptide having a function equivalent to OR51B6 is a polypeptide having an amino acid sequence having at least 80% identity with the amino acid sequence shown in SEQ ID NO: 13, at least 10%, more preferably at least 30%, even more preferably at least 50%, even more preferably at least 70%, even more preferably at least 90%, and even more preferably at all positions corresponding to each amino acid position of (1) in the amino acid sequence shown in SEQ ID NO: 13 in Table 3 below, and having an amino acid residue of (2) at each position, and having responsiveness to octanal. In addition, in the amino acid sequence shown in SEQ ID NO: 13, a polypeptide having amino acid residues (2) at all of the amino acid positions (1) in Table 3 below is consensus OR51B6 consisting of the amino acid sequence shown in SEQ ID NO: 15. In other words, Table 3 below shows the amino acid residues that differ between OR51B6 and consensus OR51B6.

[0052] Another example of a polypeptide having a function equivalent to OR51B6 includes a polypeptide consisting of consensus OR51B6 consisting of the amino acid sequence shown in SEQ ID NO: 15 or an amino acid sequence having at least 90% identity thereto, and having responsiveness to octanal. Consensus OR51B6 consists of the consensus amino acid sequence shown in SEQ ID NO: 15, which is derived by the above-mentioned method from the alignment of the amino acid sequence of OR51B6 shown in SEQ ID NO: 13 and the amino acid sequences of 163 olfactory receptors encoded by orthologues of OR51B6 in mammals, and has responsiveness to octanal. The orthologue is a gene that is highly homologous to OR51B6 among olfactory receptor genes possessed by organisms belonging to mammals, and is a gene that includes the same name as OR51B6. The amino acid sequence identity between consensus OR51B6 and OR51B6 is 93%.

[0053] An example of a polypeptide having a function equivalent to OR10H5 includes a polypeptide having an amino acid sequence having at least 80% identity with the amino acid sequence shown in SEQ ID NO: 16 and having responsiveness to octanal. Another example of a polypeptide having a function equivalent to OR10H5 is a polypeptide having an amino acid sequence having at least 80% identity with the amino acid sequence shown in SEQ ID NO: 16, at least one position, preferably at least three positions, more preferably at least five positions, even more preferably at least 10 positions, and even more preferably at all positions corresponding to each amino acid position of (3) in the amino acid sequence shown in SEQ ID NO: 16 in Table 3 below, and having an amino acid residue of (4) at each position, and having responsiveness to octanal. Yet another example of a polypeptide having a function equivalent to OR10H5 is a polypeptide having an amino acid sequence having at least 80% identity with the amino acid sequence shown in SEQ ID NO: 16, at least 10%, more preferably at least 30%, even more preferably at least 50%, even more preferably at least 70%, even more preferably at least 90%, and even more preferably at all positions corresponding to each amino acid position of (3) in the amino acid sequence shown in SEQ ID NO: 16 in Table 3 below, and having an amino acid residue of (4) at each position, and having responsiveness to octanal. In addition, in the amino acid sequence shown in SEQ ID NO: 16, a polypeptide having amino acid residues of (4) at all of the amino acid positions of (3) in Table 3 below is consensus OR10H5 consisting of the amino acid sequence shown in SEQ ID NO: 18. In other words, Table 3 below shows the amino acid residues that differ between OR10H5 and consensus OR10H5.

[0054] Another example of a polypeptide having a function equivalent to OR10H5 includes a polypeptide consisting of consensus OR10H5 consisting of the amino acid sequence shown in SEQ ID NO: 18 or an amino acid sequence having at least 90% identity thereto, and having responsiveness to octanal. Consensus OR10H5 consists of the consensus amino acid sequence shown in SEQ ID NO: 18, which is derived by the above-mentioned method from the alignment of the amino acid sequence of OR10H5 shown in SEQ ID NO: 16 and the amino acid sequences of 25 olfactory receptors encoded by orthologues of OR10H5 in mammals, and has responsiveness to octanal. The orthologue is a gene that is highly homologous to OR10H5 among olfactory receptor genes possessed by organisms belonging to mammals, and is a gene that includes the same name as OR10H5. The amino acid sequence identity between consensus OR10H5 and OR10H5 is 95%.

[0055] An example of a polypeptide having a function equivalent to OR2B2 includes a polypeptide consisting of an amino acid sequence having at least 80% identity with the amino acid sequence shown in SEQ ID NO: 19 and having responsiveness to octanal. Another example of a polypeptide having a function equivalent to OR2B2 is a polypeptide having an amino acid sequence having at least 80% identity with the amino acid sequence shown in SEQ ID NO: 19, at least one, preferably at least three, more preferably at least five, even more preferably at least 10, and even more preferably all of the positions corresponding to the amino acid positions (5) in Table 3 of the amino acid sequence shown in SEQ ID NO: 19, and having an amino acid residue (6) at each position, and having responsiveness to octanal. Yet another example of a polypeptide having a function equivalent to OR2B2 is a polypeptide having an amino acid sequence having at least 80% identity with the amino acid sequence shown in SEQ ID NO: 19, at least 10%, more preferably at least 30%, even more preferably at least 50%, even more preferably at least 70%, even more preferably at least 90%, and even more preferably at all of the positions corresponding to the amino acid positions (5) in Table 3 of the amino acid sequence shown in SEQ ID NO: 19, and having an amino acid residue (6) at each position, and having responsiveness to octanal. In addition, in the amino acid sequence shown in SEQ ID NO: 19, a polypeptide having amino acid residues (6) at all of the amino acid positions (5) in Table 3 below is consensus OR2B2 consisting of the amino acid sequence shown in SEQ ID NO: 21. In other words, Table 3 below shows the amino acid residues that differ between OR2B2 and consensus OR2B2.

[0056] Another example of a polypeptide having a function equivalent to OR2B2 includes a polypeptide consisting of consensus OR2B2, which consists of the amino acid sequence shown in SEQ ID NO: 21, or an amino acid sequence having at least 90% identity thereto, and which is responsive to octanal. Consensus OR2B2 consists of the consensus amino acid sequence shown in SEQ ID NO: 21, which is derived by the above-mentioned method from the alignment of the amino acid sequence of OR2B2 shown in SEQ ID NO: 19 and the amino acid sequences of 156 olfactory receptors encoded by orthologues of OR2B2 in mammals, and has responsiveness to octanal. The orthologue is a gene that is highly homologous to OR2B2 among olfactory receptor genes possessed by organisms belonging to mammals, and is a gene that includes the same name as OR2B2. The amino acid sequence identity between consensus OR2B2 and OR2B2 is 80%.

[0057] An example of a polypeptide having a function equivalent to OR2A1 includes a polypeptide consisting of an amino acid sequence having at least 80% identity with the amino acid sequence shown in SEQ ID NO: 22 and having responsiveness to octanal. Another example of a polypeptide having a function equivalent to OR2A1 is a polypeptide having an amino acid sequence having at least 80% identity with the amino acid sequence shown in SEQ ID NO: 22, at least one position, preferably at least three positions, more preferably at least five positions, even more preferably at least 10 positions, and even more preferably at all positions corresponding to each amino acid position (7) in the amino acid sequence shown in SEQ ID NO: 22 in Table 3 below, and having an amino acid residue (8) at each position, and having responsiveness to octanal. Yet another example of a polypeptide having a function equivalent to OR2A1 is a polypeptide having an amino acid sequence having at least 80% identity with the amino acid sequence shown in SEQ ID NO: 22, at least 10%, more preferably at least 30%, even more preferably at least 50%, even more preferably at least 70%, even more preferably at least 90%, and even more preferably at all positions corresponding to each amino acid position (7) in the amino acid sequence shown in SEQ ID NO: 22 in Table 3 below, and having an amino acid residue (8) at each position, and having responsiveness to octanal. Here, having a QLE of (8) at the amino acid position corresponding to the C-terminus of (7) in Table 3 below means that in a certain amino acid sequence, a QLE is added to the C-terminus side of the position corresponding to the last amino acid position of the amino acid sequence shown in SEQ ID NO: 22. Note that in the amino acid sequence shown in SEQ ID NO: 22, a polypeptide having amino acid residues of (8) at all of the amino acid positions of (7) in Table 3 below is consensus OR2A1 consisting of the amino acid sequence shown in SEQ ID NO: 24. In other words, Table 3 below shows the amino acid residues that differ between OR2A1 and consensus OR2A1.

[0058] Another example of a polypeptide having a function equivalent to OR2A1 includes a polypeptide consisting of consensus OR2A1 consisting of the amino acid sequence shown in SEQ ID NO: 24 or an amino acid sequence having at least 90% identity thereto, and having responsiveness to octanal. The consensus OR2A1 is composed of the consensus amino acid sequence shown in SEQ ID NO: 24, which is derived by the above-mentioned method from the alignment of the amino acid sequence of OR2A1 shown in SEQ ID NO: 22 and the amino acid sequences of 159 olfactory receptors encoded by orthologues of OR2A1 in mammals, and has responsiveness to octanal. The orthologue is a gene that is highly homologous to OR2A1 among olfactory receptor genes possessed by organisms belonging to mammals, and is a gene that includes the same name as OR2A1. The amino acid sequence identity between the consensus OR2A1 and OR2A1 is 92%.

[0059] An example of a polypeptide having a function equivalent to OR2C1 includes a polypeptide consisting of an amino acid sequence having at least 80% identity with the amino acid sequence shown in SEQ ID NO: 25 and having responsiveness to octanal. Another example of a polypeptide having a function equivalent to OR2C1 is a polypeptide having an amino acid sequence having at least 80% identity with the amino acid sequence shown in SEQ ID NO: 25, at least one position, preferably at least three positions, more preferably at least five positions, even more preferably at least 10 positions, and even more preferably at all positions corresponding to each amino acid position of (1) in the amino acid sequence shown in SEQ ID NO: 25 in Table 4 below, and having an amino acid residue of (2) at each position, and having responsiveness to octanal. Yet another example of a polypeptide having a function equivalent to OR2C1 is a polypeptide having an amino acid sequence having at least 80% identity with the amino acid sequence shown in SEQ ID NO: 25, at least 10%, more preferably at least 30%, even more preferably at least 50%, even more preferably at least 70%, even more preferably at least 90%, and even more preferably at all positions corresponding to each amino acid position of (1) in the amino acid sequence shown in SEQ ID NO: 25 in Table 4 below, and having an amino acid residue of (2) at each position, and having responsiveness to octanal. In addition, in the amino acid sequence shown in SEQ ID NO: 25, a polypeptide having amino acid residues (2) at all of the amino acid positions (1) in Table 4 below is consensus OR2C1 consisting of the amino acid sequence shown in SEQ ID NO: 27. In other words, Table 4 below shows the amino acid residues that differ between OR2C1 and consensus OR2C1.

[0060] Another example of a polypeptide having a function equivalent to OR2C1 includes a polypeptide consisting of consensus OR2C1 consisting of the amino acid sequence shown in SEQ ID NO: 27 or an amino acid sequence having at least 90% identity thereto, and having responsiveness to octanal. Consensus OR2C1 consists of the consensus amino acid sequence shown in SEQ ID NO: 27, which is derived by the above-mentioned method from the alignment of the amino acid sequence of OR2C1 shown in SEQ ID NO: 25 and the amino acid sequences of 89 olfactory receptors encoded by orthologues of OR2C1 in mammals, and has responsiveness to octanal. The orthologue is a gene that is highly homologous to OR2C1 among olfactory receptor genes possessed by organisms belonging to mammals, and is a gene that includes the same name as OR2C1. The amino acid sequence identity between consensus OR2C1 and OR2C1 is 92%.

[0061] [Table 2]

[0062] [Table 3]

[0063] [Table 4]

[0064] In the method of the present invention for evaluating and / or selecting an inhibitor of odor caused by aldehydes, the olfactory receptor polypeptide used may be at least one selected from OR5AR1, OR2AP1, OR5T3, OR6P1, OR51B6, OR10H5, OR2B2, OR2A1, and polypeptides having equivalent functions thereto, but any two or more types may be used in combination. Preferably, at least one selected from the group consisting of OR5AR1, OR2AP1, OR5T3, OR6P1, OR51B6, OR10H5, OR2B2, OR2A1, consensus OR5AR1, consensus OR2AP1, consensus OR5T3, consensus OR6P1, consensus OR51B6, consensus OR10H5, consensus OR2B2, and consensus OR2A1 is used, and more preferably, at least one selected from the group consisting of consensus OR5AR1, consensus OR2AP1, consensus OR5T3, consensus OR6P1, consensus OR51B6, consensus OR10H5, consensus OR2B2, and consensus OR2A1 is used. Furthermore, at least one selected from the group consisting of OR2C1 and polypeptides having equivalent functions thereto, preferably at least one selected from the group consisting of OR2C1 and consensus OR2C1, more preferably consensus OR2C1, may be used in combination.

[0065] In one example, when the aldehyde is trans-2-nonenal, the olfactory receptor polypeptide is preferably at least one selected from the group consisting of OR5AR1 and polypeptides having equivalent functions thereto, more preferably at least one selected from the group consisting of OR5AR1 and consensus OR5AR1, and even more preferably consensus OR5AR1.

[0066] In another example, when the aldehyde is octanal, the olfactory receptor polypeptide is preferably at least one selected from the group consisting of OR2AP1, OR5T3, OR6P1, OR51B6, OR10H5, OR2B2, OR2A1, and polypeptides having equivalent functions thereto, and more preferably, OR2AP1, OR5T3, OR6P1, OR51B6, OR10H5, OR2B2, OR2A1, consensus OR2AP1, consensus OR At least one selected from the group consisting of 5T3, consensus OR6P1, consensus OR51B6, consensus OR10H5, consensus OR2B2 and consensus OR2A1 is used, more preferably at least one selected from the group consisting of consensus OR2AP1, consensus OR5T3, consensus OR6P1, consensus OR51B6, consensus OR10H5, consensus OR2B2 and consensus OR2A1 is used. Furthermore, at least one selected from the group consisting of OR2C1 and polypeptides having equivalent functions thereto, preferably at least one selected from the group consisting of OR2C1 and consensus OR2C1, more preferably consensus OR2C1 may be used in combination.

[0067] In the method for evaluating and / or selecting an octanal odor suppressant of the present invention, at least one selected from the group consisting of OR2C1 and polypeptides having equivalent functions thereto may be used as the olfactory receptor polypeptide, but any two or more may be used in combination. Preferably, at least one selected from the group consisting of OR2C1 and consensus OR2C1 is used, and more preferably, consensus OR2C1 is used.

[0068] In the method for evaluating and / or selecting an inhibitor of odor caused by aldehyde of the present invention, the olfactory receptor polypeptide can be used in any form as long as it does not lose its responsiveness to aldehyde.For example, the olfactory receptor polypeptide can be used in the form of tissues or cells that naturally express the olfactory receptor polypeptide, such as olfactory receptors or olfactory cells isolated from living organisms, or cultures thereof; the membrane of olfactory cells carrying the olfactory receptor polypeptide; recombinant cells genetically engineered to express the olfactory receptor polypeptide or cultures thereof; the membrane of the recombinant cell carrying the olfactory receptor polypeptide; artificial lipid bilayer membrane carrying the olfactory receptor polypeptide, etc.All of these forms are included in the scope of the olfactory receptor polypeptide used in the present invention.

[0069] In a preferred embodiment, the olfactory receptor polypeptide is a cell that naturally expresses the olfactory receptor polypeptide, such as an olfactory cell, or a recombinant cell genetically engineered to express the olfactory receptor polypeptide, or a culture thereof. The recombinant cell can be prepared by transforming a cell with a vector incorporating a gene encoding the olfactory receptor polypeptide.

[0070] Preferably, in order to promote the cell membrane expression of the olfactory receptor polypeptide, a gene encoding an RTP (receptor-transporting protein) is introduced into the cell together with the gene encoding the olfactory receptor polypeptide. Preferably, a gene encoding RTP1S is introduced into the cell together with the gene encoding the olfactory receptor polypeptide. An example of RTP1S is human RTP1S. Human RTP1S is registered in GenBank as GI:50234917, and is a polypeptide consisting of the amino acid sequence of SEQ ID NO:29, encoded by a gene having the nucleotide sequence of SEQ ID NO:28.

[0071] Methods for adding a test substance to the olfactory receptor polypeptide include, but are not limited to, adding the test substance to a culture medium in which cells expressing the olfactory receptor polypeptide are cultured, and directly adding, dripping, sprinkling or spraying the test substance onto the olfactory receptor polypeptide or cells or tissues containing it.

[0072] In the method for evaluating and / or selecting an inhibitor of an odor caused by aldehyde of the present invention, the response of the olfactory receptor polypeptide is measured following the addition of a test substance to the olfactory receptor polypeptide. The measurement may be performed by any method known in the art as a method for measuring the response of an olfactory receptor, such as measuring the amount of intracellular cAMP. For example, it is known that when an olfactory receptor is activated by an odor molecule, it conjugates with a G protein α subunit classified as the Gαs family in the cell to activate adenylate cyclase, thereby increasing the amount of intracellular cAMP (Nat. Neurosci., 2004, 5:263-278). On the other hand, when an olfactory receptor is activated by an odor molecule, it can also conjugate with a protein belonging to the Gq family, such as Gα15, in the cell, and increase the amount of calcium ions in the cell. Therefore, the response of the olfactory receptor polypeptide can be measured by using the amount of intracellular cAMP or calcium ion after the addition of an odor molecule, or the behavior of downstream molecules activated through them as an index. Methods for measuring the amount of cAMP include ELISA, reporter gene assay, and a method using a cAMP-responsive reporter protein. In a method using a cAMP-responsive reporter protein, for example, a firefly luciferase genetically modified to contain a portion of a cAMP-binding protein is used, and the amount of cAMP is measured by monitoring the luminescence value of the luciferase corresponding to the amount of cAMP (GloSensor (trademark) cAMP Assay (Promega)). As another method for measuring the response of an olfactory receptor polypeptide, a method for measuring calcium ion concentration includes a calcium imaging method and a TGFα shedding assay. In addition, as an example of a method using the behavior of downstream molecules activated via the amount of cAMP as an index, a two-electrode voltage clamp method is also effective for measuring the potential change inside and outside the cell membrane via the cystic fibrosis transmembrane conductance regulator CFTR, which is activated by a cAMP signal, in Xenopus oocytes.

[0073] In a first embodiment of the present invention, the method for evaluating and / or selecting an inhibitor of an aldehyde-induced odor according to the present invention comprises adding a test substance to the above-mentioned olfactory receptor polypeptide; and measuring the response of the olfactory receptor polypeptide to the test substance. Then, based on the measured response, a test substance that enhances the response of the olfactory receptor polypeptide is detected. The detected test substance is selected as an inhibitor of an aldehyde-induced odor.

[0074] The test substance that enhances the response of the olfactory receptor polypeptide can weaken the response of the olfactory receptor when it is exposed to aldehyde later by enhancing the response of the olfactory receptor in advance.As a result, it can suppress the recognition of the odor caused by aldehyde by an individual based on odor cross-adaptation.Therefore, in the first embodiment, the suppressor of the odor caused by aldehyde is selected based on the odor cross-adaptation by olfactory receptor agonism.

[0075] The effect of the test substance on the olfactory receptor polypeptide can be evaluated, for example, by comparing the response of the olfactory receptor polypeptide to which the test substance has been added (test group) with the response in a control group. Examples of the control group include the olfactory receptor polypeptide to which no test substance has been added, the olfactory receptor polypeptide to which a control substance has been added, the olfactory receptor polypeptide to which a lower concentration of a test substance has been added, the olfactory receptor polypeptide before the addition of a test substance, and cells in which the olfactory receptor polypeptide is not expressed. Preferably, the method for evaluating and / or selecting an aldehyde-induced odor suppressant of the present invention in the first embodiment includes measuring the activity of the olfactory receptor polypeptide in the presence and absence of a test substance. Also preferably, the method for evaluating and / or selecting an aldehyde-induced odor suppressant of the present invention in the first embodiment includes measuring the response of cells in which the olfactory receptor polypeptide is expressed and cells in which the olfactory receptor polypeptide is not expressed to the test substance in the presence of a test substance.

[0076] For example, if the response in the test group is enhanced compared to the control group, the test substance can be selected as a substance that suppresses the response of the olfactory receptor polypeptide to aldehyde.For example, if the response of the olfactory receptor polypeptide in the test group is enhanced preferably by 120% or more, more preferably by 150% or more, and even more preferably by 200% compared to the control group, the test substance can be selected as a substance that suppresses the response of the olfactory receptor polypeptide to aldehyde.Alternatively, if the response of the olfactory receptor polypeptide in the test group is statistically significantly enhanced compared to the control group, the test substance can be selected as a substance that suppresses the response of the olfactory receptor polypeptide to aldehyde.

[0077] Examples of odors caused by aldehydes that are suppressed by the aldehyde odor suppressor selected according to the first embodiment include body odor, elderly odor, trans-2-nonenal odor, and octanal odor. Preferably, when OR5AR1 or a polypeptide having a function equivalent thereto is used as the olfactory receptor, examples include body odor, elderly odor, and trans-2-nonenal odor, and when OR5AR1, OR2AP1, OR5T3, OR6P1, OR51B6, OR10H5, OR2B2, OR2A1, or a polypeptide having a function equivalent thereto is used, examples include body odor and octanal odor. Preferably, when OR2C1 or a polypeptide having a function equivalent thereto is used, examples include body odor and octanal odor. More preferably, it is body odor.

[0078] An embodiment of the use of the aldehyde odor suppressant selected according to the first embodiment is as follows: first, the subject who desires to suppress the aldehyde odor is made to smell the suppressant before the subject is exposed to the odor. Alternatively, the suppressant is applied to the subject so that the odor is stronger than the aldehyde odor. As a result, even if the subject is exposed to the aldehyde odor, the subject feels the odor weak or does not feel it because the olfactory sensitivity to the odor is reduced.

[0079] In a second embodiment of the present invention, the method for evaluating and / or selecting an inhibitor of an aldehyde-induced odor according to the present invention comprises adding a test substance and an agonist of the olfactory receptor polypeptide to the above-mentioned olfactory receptor polypeptide; and measuring the response of the olfactory receptor polypeptide to the agonist. The agonist is not limited to, but is preferably at least one selected from the group consisting of aldehydes, more preferably trans-2-nonenal and octanal. More preferably, when OR5AR1 or a polypeptide having an equivalent function thereto is used as the olfactory receptor, trans-2-nonenal is used, and when OR5AR1, OR2AP1, OR5T3, OR6P1, OR51B6, OR10H5, OR2B2, OR2A1, OR2C1 or a polypeptide having an equivalent function thereto is used, octanal is used. Then, based on the measured response, a test substance that inhibits the response of the olfactory receptor polypeptide to the agonist is detected. The detected test substances are selected as inhibitors of odor caused by aldehydes.

[0080] In the second embodiment, a test substance that inhibits the response of the olfactory receptor polypeptide to an agonist of the olfactory receptor polypeptide is selected as an inhibitor of aldehyde-induced odor based on olfactory receptor antagonism.

[0081] The effect of the test substance on the response of the olfactory receptor polypeptide to the agonist can be measured, for example, by comparing the response of the olfactory receptor polypeptide to which the test substance has been added (test group) to the agonist with the response of the control group to the agonist. Examples of the control group include those described above. Preferably, the method for evaluating and / or selecting an aldehyde-induced odor suppressant of the present invention in the second embodiment includes measuring the activity of the olfactory receptor polypeptide against the agonist in the presence and absence of a test substance.

[0082] For example, if the response in the test group is more suppressed than that in the control group, the test substance can be selected as a substance that suppresses the response of the olfactory receptor polypeptide to aldehyde.For example, if the response of the olfactory receptor polypeptide in the test group is preferably suppressed to 60% or less, more preferably 50% or less, and even more preferably 25% or less compared to the control group, the test substance can be selected as a substance that suppresses the response of the olfactory receptor polypeptide to aldehyde.Alternatively, if the response of the olfactory receptor polypeptide in the test group is statistically significantly suppressed compared to the control group, the test substance can be selected as a substance that suppresses the response of the olfactory receptor polypeptide to aldehyde.

[0083] Examples of aldehyde-caused odors suppressed by the aldehyde-caused odor suppressor selected according to the second embodiment include odors similar to the aldehyde-caused odors suppressed by the aldehyde-caused odor suppressor selected according to the first embodiment described above.

[0084] One embodiment of the use of the aldehyde odor suppressant selected according to the second embodiment is as follows: first, the subject who desires to suppress the aldehyde odor is made to smell the suppressant before or at the same time that the subject is exposed to the odor.As a result, even if the subject is exposed to the aldehyde odor, because the olfactory sensitivity to the odor is reduced, the subject feels the odor weakly or does not feel it at all.

[0085] By the above procedure, an inhibitor of an aldehyde-induced odor can be obtained based on the response activity of the olfactory receptor polypeptide responsive to an aldehyde-induced odor. If necessary, the ability of the above-selected test substance to inhibit an aldehyde-induced odor may be further evaluated by a sensory test. That is, in one embodiment of the method for evaluating and / or selecting an inhibitor of an aldehyde-induced odor of the present invention, the test substance selected by the above procedure is obtained as a candidate substance for an inhibitor of an aldehyde-induced odor. Then, the inhibitory effect of the candidate substance on an aldehyde-induced odor is evaluated by a sensory test. The candidate substance that is evaluated better in the sensory test is selected as an inhibitor of an aldehyde-induced odor.

[0086] The sensory test of the candidate substance can be performed according to the evaluation procedure of deodorants that is usually performed in the field. If the candidate substance is an inducer of cross-adaptation of odor, the order of application of the candidate substance and the substance causing the target odor to the evaluator can be adjusted. For example, when the test substance selected in the first embodiment described above is used as a candidate substance for sensory test, the evaluator first smells the candidate substance and adapts to the odor. Then, the evaluator smells the target odor (preferably an odor caused by aldehyde) and evaluates its intensity. The obtained evaluation result is compared with the intensity of the target odor when the candidate substance is not adapted. Also, for example, when the test substance selected in the second embodiment described above is used as a candidate substance for sensory test, the evaluator smells the target odor (preferably an odor caused by aldehyde) at the same time as the candidate substance, and evaluates the intensity of the target odor. The obtained evaluation result is compared with the intensity of the target odor alone. Candidate substances that are evaluated as reducing the intensity of the target odor as a result of the sensory test are selected as inhibitors of odors caused by aldehydes.

[0087] The aldehyde odor suppressant obtained by the method for evaluating and / or selecting an aldehyde odor suppressant of the present invention can be used as an active ingredient for suppressing aldehyde odor.For example, the suppressant can be contained in a composition or article for suppressing aldehyde odor as an active ingredient for suppressing aldehyde odor.Alternatively, the suppressant can be used for the manufacture of a composition or article for suppressing aldehyde odor. Examples of applications of the aldehyde odor suppressant obtained by the method of the present invention for evaluating and / or selecting an aldehyde odor suppressant include, but are not limited to, sanitary products such as sanitary products and disposable diapers containing the agent; clothing accessories such as underwear, undergarments, and linens, cloth products, or textiles containing the agent; laundry detergents or fabric softeners containing the agent; topical agents such as cosmetics, cleaning agents, and deodorants, medicines, foods, etc. containing the agent; placing or spraying the agent in entranceways, shoe cupboards, bedrooms, or living rooms; placing or spraying the agent in cars; placing or spraying the agent in hospital wards or nursing facilities, etc.; and application to environments where aldehyde odors are generated.

[0088] The matters described in relation to the method for evaluating and / or selecting an octanal odor inhibitor of the present invention can be appropriately applied to the method for evaluating and / or selecting an inhibitor of an odor caused by an aldehyde of the present invention by replacing aldehyde with octanal and odor caused by an aldehyde with octanal odor, respectively.

[0089] As described above, OR5AR1, OR2AP1, OR5T3, OR6P1, OR51B6, OR10H5, OR2B2, and OR2A1 are newly discovered aldehyde receptors, and therefore, by using OR5AR1, OR2AP1, OR5T3, OR6P1, OR51B6, OR10H5, OR2B2, OR2A1, or a polypeptide having a function equivalent thereto, an odor caused by an aldehyde can be detected. Therefore, the present invention provides a method for detecting an odor caused by an aldehyde. The method includes contacting a sample with at least one olfactory receptor polypeptide selected from the group consisting of OR5AR1, OR2AP1, OR5T3, OR6P1, OR51B6, OR10H5, OR2B2, OR2A1, and a polypeptide having a function equivalent thereto; and measuring the response of the olfactory receptor polypeptide to the sample. Based on the measured response, an odor caused by an aldehyde contained in the sample is detected.

[0090] As described above, since OR2C1 is a newly discovered octanal receptor, octanal odor can be detected by using OR2C1 or a polypeptide having an equivalent function. Therefore, the present invention provides a method for detecting octanal odor. The method includes contacting a sample with at least one olfactory receptor polypeptide selected from the group consisting of OR2C1 and polypeptides having an equivalent function; and measuring the response of the olfactory receptor polypeptide to the sample. The octanal odor contained in the sample is detected based on the measured response.

[0091] Here, the term "detection" can also be replaced with "evaluation" or "measurement." "Detection of an odor caused by an aldehyde" includes verification of the presence or absence of an odor caused by an aldehyde and measurement of the degree of the odor caused by an aldehyde, and "detection of an octanal odor" includes verification of the presence or absence of an octanal odor and measurement of the degree of the octanal odor.

[0092] The sample used in the method for detecting odor caused by aldehyde of the present invention is not particularly limited as long as it is a sample for which confirmation of the presence or absence or the level of odor caused by aldehyde is desired.The sample may be a compound, a composition, or a mixture, and may be a gas, a liquid, or a solid.The sample is preferably a real sample, and examples of the real sample include samples derived from body fluids (e.g., saliva, sweat, urine), wastewater, food, fragrances, cosmetics, medicines, detergents, daily necessities, and laundry.

[0093] The olfactory receptor polypeptide and its form used in the method for detecting odors caused by aldehydes of the present invention are similar to the olfactory receptor polypeptide and its form used in the method for evaluating and / or selecting inhibitors of odors caused by aldehydes of the present invention.

[0094] Methods for contacting a sample with the olfactory receptor polypeptide include, but are not limited to, adding the sample to a culture medium in which cells expressing the olfactory receptor polypeptide are cultured, and directly adding, dripping, scattering or spraying the sample onto the olfactory receptor polypeptide or onto cells or tissues containing the same.

[0095] The response of the olfactory receptor polypeptide can be measured using a method similar to that used in the present invention for evaluating and / or selecting an agent for suppressing odor caused by aldehydes.

[0096] In the method for detecting odor caused by aldehyde of the present invention, the odor caused by aldehyde in the sample is detected based on the measured response.The sample that causes the response of the olfactory receptor polypeptide can be evaluated as a sample that exhibits an odor caused by aldehyde, in other words, a sample that contains aldehyde.The higher the response intensity caused by the sample, the higher the level of the odor caused by aldehyde exhibited by the sample, in other words, the more aldehyde is evaluated to be contained in the sample.

[0097] Preferably, the response of the olfactory receptor polypeptide to a sample can be evaluated by comparing the response of the olfactory receptor polypeptide (test group) contacted with a sample with the response of the olfactory receptor polypeptide in a control group. The control group can include the olfactory receptor polypeptide to which no sample has been added, the olfactory receptor polypeptide to which a control substance has been added, the olfactory receptor polypeptide contacted with a lower concentration of sample, the olfactory receptor polypeptide before contacting with a sample, etc. If the response in the test group is higher than that in the control group, the sample is evaluated as a sample that exhibits an odor caused by aldehyde.

[0098] Therefore, in one embodiment of the method for detecting odor caused by aldehyde of the present invention, the response of the olfactory receptor polypeptide is measured in the presence and absence of sample, and then it is determined whether the response in the presence of sample is higher than the response in the absence of sample.If the response in the presence of sample is higher, the sample is evaluated as a sample that exhibits an odor caused by aldehyde.In a preferred embodiment, if the response intensity of the olfactory receptor polypeptide in the presence of sample is preferably 120% or more, more preferably 150% or more, and even more preferably 200% or more compared to the absence of sample, the sample is evaluated as a sample that exhibits an odor caused by aldehyde.In another preferred embodiment, if the response intensity of the olfactory receptor polypeptide in the presence of sample is statistically significantly increased compared to the absence of sample, the sample is evaluated as a sample that exhibits an odor caused by aldehyde.

[0099] Alternatively, the response of the olfactory receptor polypeptide to a sample can be evaluated by comparing the response of the olfactory receptor polypeptide (test group) contacted with a sample with a calibration curve prepared in advance from the response when a standard sample containing an aldehyde of known concentration is used as the sample. If the response in the test group is within the quantitative range of the calibration curve, the sample is evaluated as a sample that exhibits an odor caused by an aldehyde, and the level of the odor can be calculated based on the calibration curve.

[0100] Examples of odors caused by aldehydes detected by the method for detecting an odor caused by aldehydes of the present invention include body odor, elderly odor, trans-2-nonenal odor, and octanal odor. When OR5AR1 or a polypeptide having a function equivalent thereto is used as the olfactory receptor, preferably, body odor, elderly odor, and trans-2-nonenal odor are included, and when OR5AR1, OR2AP1, OR5T3, OR6P1, OR51B6, OR10H5, OR2B2, OR2A1, or a polypeptide having a function equivalent thereto are used, body odor and octanal odor are included. More preferably, it is body odor.

[0101] The matters described in relation to the method for detecting an odor caused by an aldehyde of the present invention can be appropriately applied to the method for detecting an octanal odor of the present invention by replacing aldehyde with octanal and the odor caused by an aldehyde with octanal odor, respectively. EXAMPLES

[0102] The present invention will be described more specifically below with reference to examples.

[0103] Example 1 Identification of olfactory receptors that respond to aldehydes 1) Creation of olfactory receptor expressing cells A consensus olfactory receptor was designed in the same manner as described in the Examples of Patent Document 4. In designing the consensus olfactory receptor, a search for homologous gene candidates of the target olfactory receptor gene was performed using NCBI BLAST. Orthologs of the obtained gene group were identified. Specifically, from the top homologous genes searched by BLAST, genes with the same name as the target olfactory receptor were selected as orthologs. For example, in the case of human OR5AR1, the amino acid sequence of human OR5AR1 (NP_001004730.1) was used as the query sequence, and 27 genes with OR5AR1 in their name were selected from the top 250 homologous genes searched by BLAST. These 27 genes were identified as orthologs. For the amino acid sequences of these 27 genes and human OR5AR1, a total of 28 genes were subjected to alignment analysis and consensus amino acid identification as described below. Consensus amino acids were also identified for other human olfactory receptors, OR2AP1, OR5T3, OR6P1, OR51B6, OR10H5, OR2B2, OR2A1, and OR2C1.

[0104] The alignment analysis of the identified gene group was performed using ClustalW, and further adjustments were made to optimize the olfactory receptors based on amino acids or amino acid motifs highly conserved among olfactory receptors. Based on the alignment results, a consensus olfactory receptor was designed using Jalview. In the alignment, when there is one amino acid residue different from the amino acid residue of the reference amino acid sequence and has an occurrence frequency of 50% or more at a position corresponding to each amino acid position of the original human olfactory receptor amino acid sequence serving as a reference, the amino acid residue of the reference amino acid sequence was modified to the amino acid residue. Even if there is one amino acid residue different from the amino acid residue of the reference amino acid sequence and has an occurrence frequency of 50% at a position corresponding to each amino acid position of the original human olfactory receptor amino acid sequence serving as a reference, if the occurrence frequency of the amino acid residue of the reference amino acid sequence is also 50%, the amino acid residue of the reference amino acid sequence was not modified. In the alignment, when there is a deletion with an occurrence frequency of 40% or more at a position corresponding to each amino acid position of the original human olfactory receptor amino acid sequence serving as a reference, the amino acid residue of the reference amino acid sequence was modified to a deletion. On the other hand, when an amino acid with an occurrence frequency of 60% or more exists at a position corresponding to the deletion position of the original reference human olfactory receptor amino acid sequence, the reference amino acid sequence was modified to insert the most conserved amino acid at the deletion position. When there are two or more types of the most conserved amino acid, the amino acid with the smallest molecular weight was modified to insert. The topology of the olfactory receptor in the design was confirmed using TMHMM (Transmembrane Hidden Markov Model). The DNA sequences encoding the various designed olfactory receptor polypeptides were obtained by DNA synthesis after optimizing the base sequence codons corresponding to the amino acid sequences for expression in human cultured cells. The base sequences with optimized codons encoding consensus OR5AR1, consensus OR2AP1, consensus OR5T3, consensus OR6P1, consensus OR51B6, consensus OR10H5, consensus OR2B2, consensus OR2A1, and consensus OR2C1 consisting of the amino acid sequences shown in SEQ ID NOs: 3, 6, 9, 12, 15, 18, 21, 24, and 27 are shown in SEQ ID NOs: 2, 5, 8, 11, 14, 17, 20, 23, and 26, respectively. EcoRI and XhoI sites were added to both ends of this base sequence, and it was recombined into the EcoRI and XhoI sites created downstream of the Flag-Rho tag sequence on the pME18S vector. In addition, a gene encoding human RTP1S, which transports olfactory receptor proteins produced in cultured cells onto the cell membrane, was inserted into the EcoRI and XhoI sites of another pME18S vector to create the pME18S-RTP1S vector.

[0105] A reaction solution with the composition shown in Table 5 was prepared, left to stand in a clean bench for 20 minutes, and then added to each well of a 96-well plate (BD). For the olfactory receptor OR5T3, the composition shown in Table 6 was used, and for OR6P1, OR51B6, OR2A1, and OR2C1, the composition shown in Table 7 was used. Next, 100 μL of HEK293 cells suspended in DMEM (Nacalai) were added to each well at 2 × 10 5 cells / cm 2 The cells were seeded at 100°C and cultured for 24 hours in an incubator maintained at 37°C and 5% CO2. As a control, cells that do not express olfactory receptors (Mock) were prepared.

[0106] [Table 5]

[0107] [Table 6]

[0108] [Table 7]

[0109] 2) Luciferase assay Olfactory receptors expressed in HEK293 cells increase the amount of intracellular cAMP by coupling with endogenous GαS and activating adenylate cyclase. To measure odor responses, a luciferase reporter gene assay was used to monitor the increase in intracellular cAMP as luminescence values ​​derived from the firefly luciferase gene (fluc2P-CRE-hygro). In addition, a Renilla luciferase gene fused downstream of the CMV promoter (hRluc2P-CMV-hygro) was simultaneously transfected and used as an internal standard to correct errors in gene transfection efficiency and cell number.

[0110] The medium was removed from the culture prepared in 1) above, and 75 μL of test substance solution (final concentration: 100 μM each of trans-2-nonenal (CAS: 18829-56-6, Tokyo Chemical Industry) or octanal (CAS: 124-13-0, Fujifilm Wako Pure Chemical Industries)) prepared in new medium was added. The cells were cultured in a CO2 incubator for 4 hours to allow the luciferase gene to be fully expressed in the cells. Luciferase activity was measured using Dual-Glo TM The measurements were performed using a luciferase assay system (Promega) according to the product's operating manual. In each well of a 96-well plate, the luminescence value derived from firefly luciferase induced by stimulation with the test substance was divided by the luminescence value derived from Renilla luciferase to calculate the signal, which was used for analysis. The signal under each transfection condition was normalized by setting the signal without stimulation with odorant to 0% and the signal stimulated with 10 μM forskolin to 100%, and used as the signal (%) for analysis.

[0111] 3) Results Among the consensus olfactory receptors tested, those that responded to trans-2-nonenal or octanal are shown in Table 8. The response values ​​in Table 8 are the average values ​​of data from two replicates in one experiment. From Table 8, it was found that consensus OR5AR1 responded to trans-2-nonenal, and consensus OR2AP1, consensus OR5T3, consensus OR6P1, consensus OR51B6, consensus OR10H5, consensus OR2B2, consensus OR2A1 and consensus OR2C1 responded to octanal.

[0112] [Table 8]

[0113] The responses of consensus olfactory receptors to odorants reflect those of the original olfactory receptors in olfactory cells. Therefore, the above results identify the original OR5AR1, OR2AP1, OR5T3, OR6P1, OR51B6, OR10H5, OR2B2, OR2A1, and OR2C1 as receptors for aldehydes.

Claims

1. A method for evaluating and / or selecting an agent for suppressing odor caused by aldehydes, comprising measuring the response of at least one olfactory receptor polypeptide selected from the group consisting of OR5AR1, OR2AP1, OR5T3, OR6P1, OR51B6, OR10H5, OR2B2, OR2A1 and polypeptides having equivalent functions thereto after addition of a test substance.

2. The method of claim 1, further comprising measuring the response of at least one olfactory receptor polypeptide selected from the group consisting of OR2C1 and polypeptides having equivalent functions thereto after addition of a test substance.

3. 3. The method according to claim 1 or 2, wherein the odor caused by aldehyde is body odor.

4. The method according to any one of claims 1 to 3, wherein the aldehyde is trans-2-nonenal when the olfactory receptor polypeptide is OR5AR1 or a polypeptide having a function equivalent thereto, and is octanal when the olfactory receptor polypeptide is OR2AP1, OR5T3, OR6P1, OR51B6, OR10H5, OR2B2, OR2A1, or a polypeptide having a function equivalent thereto.

5. The method according to any one of claims 2 to 4, wherein the aldehyde is octanal when the olfactory receptor polypeptide is OR2C1 or a polypeptide having a function equivalent thereto.

6. The method according to any one of claims 1 to 5, wherein the OR5AR1 is a polypeptide consisting of the amino acid sequence represented by SEQ ID NO: 1, the OR2AP1 is a polypeptide consisting of the amino acid sequence represented by SEQ ID NO: 4, the OR5T3 is a polypeptide consisting of the amino acid sequence represented by SEQ ID NO: 7, the OR6P1 is a polypeptide consisting of the amino acid sequence represented by SEQ ID NO: 10, the OR51B6 is a polypeptide consisting of the amino acid sequence represented by SEQ ID NO: 13, the OR10H5 is a polypeptide consisting of the amino acid sequence represented by SEQ ID NO: 16, the OR2B2 is a polypeptide consisting of the amino acid sequence represented by SEQ ID NO: 19, and the OR2A1 is a polypeptide consisting of the amino acid sequence represented by SEQ ID NO:

22.

7. The method according to any one of claims 2 to 6, wherein the OR2C1 is a polypeptide consisting of the amino acid sequence shown in SEQ ID NO:

25.

8. the polypeptide having a function equivalent to OR5AR1 is a polypeptide consisting of an amino acid sequence having at least 80% identity with the amino acid sequence shown in SEQ ID NO: 1 and having responsiveness to trans-2-nonenal; the polypeptide having a function equivalent to that of OR2AP1 is a polypeptide having an amino acid sequence having at least 80% identity with the amino acid sequence shown in SEQ ID NO: 4 and having responsiveness to octanal; the polypeptide having a function equivalent to OR5T3 is a polypeptide consisting of an amino acid sequence having at least 80% identity with the amino acid sequence shown in SEQ ID NO: 7 and having responsiveness to octanal; the polypeptide having a function equivalent to OR6P1 is a polypeptide consisting of an amino acid sequence having at least 80% identity with the amino acid sequence shown in SEQ ID NO: 10 and having responsiveness to octanal; the polypeptide having a function equivalent to OR51B6 is a polypeptide having an amino acid sequence having at least 80% identity with the amino acid sequence shown in SEQ ID NO: 13 and having responsiveness to octanal; the polypeptide having a function equivalent to that of OR10H5 is a polypeptide having an amino acid sequence having at least 80% identity with the amino acid sequence shown in SEQ ID NO: 16 and having responsiveness to octanal; the polypeptide having a function equivalent to OR2B2 is a polypeptide having an amino acid sequence having at least 80% identity with the amino acid sequence shown in SEQ ID NO: 19 and having responsiveness to octanal; The polypeptide having a function equivalent to that of OR2A1 is a polypeptide having an amino acid sequence having at least 80% identity with the amino acid sequence shown in SEQ ID NO: 22 and having responsiveness to octanal. The method according to any one of claims 1 to 7.

9. The method according to any one of claims 2 to 8, wherein the polypeptide having a function equivalent to OR2C1 has an amino acid sequence having at least 80% identity with the amino acid sequence shown in SEQ ID NO:25 and is responsive to octanal.

10. the polypeptide having a function equivalent to OR5AR1 comprises an amino acid sequence having at least 80% identity with the amino acid sequence shown in SEQ ID NO: 1, has an amino acid residue of (2) at at least one position corresponding to each amino acid position of (1) in the amino acid sequence shown in SEQ ID NO: 1 in Table 1 below, and is responsive to trans-2-nonenal; The polypeptide having a function equivalent to that of OR2AP1 is a polypeptide consisting of an amino acid sequence having at least 80% identity with the amino acid sequence shown in SEQ ID NO: 4, having an amino acid residue of (4) at at least one position corresponding to each amino acid position of (3) in the amino acid sequence shown in SEQ ID NO: 4 in Table 1 below, and having responsiveness to octanal, The polypeptide having a function equivalent to OR5T3 is a polypeptide consisting of an amino acid sequence having at least 80% identity with the amino acid sequence shown in SEQ ID NO: 7, having an amino acid residue of (6) at at least one position corresponding to each amino acid position of (5) in the amino acid sequence shown in SEQ ID NO: 7 in Table 1 below, and having responsiveness to octanal, the polypeptide having a function equivalent to that of OR6P1 is a polypeptide consisting of an amino acid sequence having at least 80% identity with the amino acid sequence shown in SEQ ID NO: 10, having an amino acid residue of (8) at at least one position corresponding to each amino acid position of (7) in the amino acid sequence shown in SEQ ID NO: 10 in Table 1 below, and having responsiveness to octanal; the polypeptide having a function equivalent to OR51B6 is a polypeptide consisting of an amino acid sequence having at least 80% identity with the amino acid sequence shown in SEQ ID NO: 13, having an amino acid residue of (2) at at least one position corresponding to each amino acid position of (1) in the amino acid sequence shown in SEQ ID NO: 13 in Table 2 below, and having responsiveness to octanal; The polypeptide having a function equivalent to that of OR10H5 is a polypeptide consisting of an amino acid sequence having at least 80% identity with the amino acid sequence shown in SEQ ID NO: 16, having an amino acid residue of (4) at at least one position corresponding to each amino acid position of (3) in the amino acid sequence shown in SEQ ID NO: 16 in Table 2 below, and having responsiveness to octanal, the polypeptide having a function equivalent to OR2B2 is a polypeptide consisting of an amino acid sequence having at least 80% identity with the amino acid sequence shown in SEQ ID NO: 19, having an amino acid residue of (6) at at least one position corresponding to each amino acid position of (5) in the amino acid sequence shown in SEQ ID NO: 19 in Table 2 below, and having responsiveness to octanal; The polypeptide having a function equivalent to OR2A1 is a polypeptide consisting of an amino acid sequence having at least 80% identity with the amino acid sequence shown in SEQ ID NO:22, having an amino acid residue of (8) at at least one position corresponding to each amino acid position of (7) in the amino acid sequence shown in SEQ ID NO:22 in Table 2 below, and having responsiveness to octanal. The method according to any one of claims 1 to 9. 【Table 1】 【Table 2】

11. The method according to any one of claims 2 to 10, wherein the polypeptide having a function equivalent to OR2C1 is a polypeptide consisting of an amino acid sequence having at least 80% identity with the amino acid sequence shown in SEQ ID NO:25, having an amino acid residue of (2) at at least one position corresponding to each amino acid position of (1) in the amino acid sequence shown in SEQ ID NO:25 in Table 3 below, and having responsiveness to octanal. 【Table 3】

12. the polypeptide having a function equivalent to OR5AR1 is a polypeptide having an amino acid sequence having at least 90% identity with the amino acid sequence shown in SEQ ID NO: 3 and having responsiveness to trans-2-nonenal; the polypeptide having a function equivalent to that of OR2AP1 is a polypeptide having an amino acid sequence having at least 90% identity with the amino acid sequence shown in SEQ ID NO:6 and having responsiveness to octanal; the polypeptide having a function equivalent to OR5T3 is a polypeptide consisting of an amino acid sequence having at least 90% identity with the amino acid sequence shown in SEQ ID NO:9 and having responsiveness to octanal; The polypeptide having a function equivalent to that of OR6P1 is a polypeptide having an amino acid sequence having at least 90% identity with the amino acid sequence shown in SEQ ID NO: 12 and having responsiveness to octanal; the polypeptide having a function equivalent to OR51B6 is a polypeptide having an amino acid sequence having at least 90% identity with the amino acid sequence shown in SEQ ID NO: 15 and having responsiveness to octanal; the polypeptide having a function equivalent to that of OR10H5 is a polypeptide having an amino acid sequence having at least 90% identity with the amino acid sequence shown in SEQ ID NO: 18 and having responsiveness to octanal; the polypeptide having a function equivalent to OR2B2 is a polypeptide having an amino acid sequence having at least 90% identity with the amino acid sequence shown in SEQ ID NO:21 and having responsiveness to octanal; The polypeptide having a function equivalent to OR2A1 is a polypeptide having an amino acid sequence having at least 90% identity with the amino acid sequence shown in SEQ ID NO: 24 and having responsiveness to octanal. The method according to any one of claims 1 to 7.

13. The method according to any one of claims 2 to 7, wherein the polypeptide having a function equivalent to OR2C1 has an amino acid sequence having at least 90% identity with the amino acid sequence shown in SEQ ID NO:27 and is responsive to octanal.

14. A method for evaluating and / or selecting an octanal odor suppressant, comprising measuring the response of at least one olfactory receptor polypeptide selected from the group consisting of OR2C1 and polypeptides having equivalent functions thereto after addition of a test substance.

15. adding a test substance to the olfactory receptor polypeptide; and measuring the response of the olfactory receptor polypeptide to the test substance; The method according to any one of claims 1 to 14, comprising:

16. The method of claim 15, further comprising selecting a test substance that enhances the response of the olfactory receptor polypeptide to the test substance as an inhibitor.

17. The method of claim 15, further comprising measuring the response of the olfactory receptor polypeptide in a control group.

18. The method of claim 17, further comprising selecting as an inhibitor a test substance that enhances the response of the olfactory receptor polypeptide to the test substance compared to the control group.

19. Adding a test substance and an agonist of the olfactory receptor polypeptide to the olfactory receptor polypeptide; and measuring the response of the olfactory receptor polypeptide to the agonist; The method according to any one of claims 1 to 14, comprising:

20. The method of claim 19, further comprising selecting a test substance that inhibits the response of the olfactory receptor polypeptide to the agonist as an inhibitor.

21. The method of claim 19, further comprising measuring the response of the olfactory receptor polypeptide to the agonist in a control group.

22. The method of claim 21, further comprising selecting a test substance as an inhibitor that inhibits the response of the olfactory receptor polypeptide to the agonist compared to the control group.

23. Contacting a sample with at least one olfactory receptor polypeptide selected from the group consisting of OR5AR1, OR2AP1, OR5T3, OR6P1, OR51B6, OR10H5, OR2B2, OR2A1, and polypeptides having equivalent functions thereto; and measuring the response of the olfactory receptor polypeptide to the sample; A method for detecting an odor caused by aldehyde, comprising:

24. Contacting a sample with at least one olfactory receptor polypeptide selected from the group consisting of OR2C1 and polypeptides having equivalent functions thereto; and measuring the response of the olfactory receptor polypeptide to the sample; A method for detecting the odor of octanal, comprising:

25. The method according to any one of claims 1 to 24, wherein the response of the olfactory receptor polypeptide is measured by ELISA, measurement of intracellular cAMP levels using a reporter gene assay or a cAMP-responsive reporter protein, measurement of calcium ion levels using calcium imaging or a TGFα shedding assay, or measurement of potential changes inside and outside the cell membrane using a two-electrode voltage clamp method using Xenopus oocytes.

Images